How is the Kezar Life Sciences Inc today?

The Kezar Life Sciences Inc today is trading in the down by -0.98% at 4.03.

What is Kezar Life Sciences Inc Annual Net Profit?

Kezar Life Sciences Inc Annual Net Profit rose 17.8% in the last year to $83.74 M. Its sector's average net profit growth for the last fiscal year was -11.26%.

What is Kezar Life Sciences Inc Price to Earning Ratio?

Kezar Life Sciences Inc Price to Earning Ratio is -0.35, which is negative.

What is Kezar Life Sciences Inc Stock Price?

Kezar Life Sciences Inc Stock Price fell 47.39% and underperformed its sector by 55.83% in the past year.

What is Kezar Life Sciences Inc Quarterly Net profit?

Kezar Life Sciences Inc Quarterly Net profit rose 37.33% YoY to $20.22 M. Its sector's average net profit growth YoY for the quarter was -207.11%.

What is Kezar Life Sciences Inc Debt to Equity Ratio?

Kezar Life Sciences Inc Debt to Equity Ratio of 0.14 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Kezar Life Sciences Inc Return on Equity(ROE)?

Kezar Life Sciences Inc Return on Equity(ROE) for the last financial year was -55%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Kezar Life Sciences Inc Mutual Fund Holding?

Kezar Life Sciences Inc Mutual Fund Holding decreased by 0.19% in the last quarter to 45.59.

What is Kezar Life Sciences Inc Promoter Share Holding?

Kezar Life Sciences Inc Promoter Share Holding increased by 0.01% in the most recent quarter to 4.8%.

What is Kezar Life Sciences Inc Interest Coverage Ratio?

Kezar Life Sciences Inc Interest Coverage Ratio is -51.56, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Kezar Life Sciences Inc Institutional Holding?

Kezar Life Sciences Inc Institutional Holding increased by 4.27% in the last quarter to 98.28.

Kezar Life Sciences Inc XNAS: KZR

Kezar Life Sciences Inc Live Share Price Today, Share Analysis and Chart

Name: Kezar Life Sciences Inc: Is Infosys Ltd. worth buying?
Item: Kezar Life Sciences Inc
Rating: 1.21766675
Author: Trendlyne DVM scores

about

Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetom...

4.03 -0.04 (-0.98%)

56.10% Fall from 52W High

13,712 XNAS Volume

XNAS 19 May, 2025 4:00 PM (EDT)

Not Eligible

-

Expensive Valuation

15.7 / 100

Technically Bearish

33.0 / 100

13

1Yr Price target upside is 210%

2 analysts

Kezar Life Sciences Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Kezar Life Sciences Inc FAQ

How is Kezar Life Sciences Inc today?

Kezar Life Sciences Inc today is trading in the red, and is down by -0.98% at 4.03.

How has Kezar Life Sciences Inc performed historically?

Kezar Life Sciences Inc is currently trading down -0.98% on an intraday basis. In the past week the stock fell -4.50%. stock has been down -31.69% in the past quarter and fell -47.39% in the past year. You can view this in the overview section.